Cancer Genetics: 2Q Earnings Snapshot
RUTHERFORD, N.J. (AP) _ Cancer Genetics Inc. (CGIX) on Monday reported a loss of $3.8 million in its second quarter.
The Rutherford, New Jersey-based company said it had a loss of 7 cents per share. Losses, adjusted to account for discontinued operations, were 1 cent per share.
The diagnostics company posted revenue of $1.5 million in the period.
The company’s shares closed at 12 cents. A year ago, they were trading at $1.06.